Synerga.Fund S.A. (WSE:SNG)
Poland · Delayed Price · Currency is PLN 0.3920
0.00 (0.00%)
At close: Oct 21, 2026
Synerga.Fund Company Description
Synerga.Fund S.A. engages in the stem cell therapy business for multiple sclerosis in Poland.
It focuses on the implementation of medical project in the field of biotechnology and advanced cell therapies.
The company was founded in 2010 and is based in Kraków, Poland.
Synerga.Fund S.A.
| Country | Poland |
| Founded | 2010 |
| Industry | Software - Application |
| Sector | Technology |
| Employees | 1 |
| CEO | Tomasz Wykurz |
Contact Details
Address: ul. Cystersów 21C/130 Kraków, 31-553 Poland | |
| Phone | 48 12 654 0519 |
| Website | SYNERGAfund.com.pl |
Stock Details
| Ticker Symbol | SNG |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLMWTNS00010 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Tomasz Wykurz | Chairman of the Management Board |